A Markov model to estimate the cost-effectiveness of omacetaxane in chronic myeloid leukaemia

Authors:

Brereton NJ, Batty AJ, Foy CF and McCormick AL.

Publication Type:

Conference Proceedings – Poster

Publication Name:

13th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress

Citation:

Brereton NJ, Batty AJ, Foy CF and McCormick AL. A Markov model to estimate the cost-effectiveness of omacetaxane in chronic myeloid leukaemia. 13th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress. Prague, Czech. 6–9 November 2010. Poster PCN95.


Link to publication ⟶

⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies